Exhibit 5.1
| | | | |
August 12, 2022 | | 1271 Avenue of the Americas |
| | New York, New York 10020-1401 |
| | Tel: +1.212.906.1200 Fax: +1.212.751.4864 www.lw.com |
| | FIRM / AFFILIATE OFFICES |
| | Austin | | Milan |
| | Beijing | | Munich |
| | Boston | | New York |
| | Brussels | | Orange County |
| | Century City | | Paris |
| | Chicago | | Riyadh |
| | Dubai | | San Diego |
| | Düsseldorf | | San Francisco |
| | Frankfurt | | Seoul |
| | Hamburg | | Shanghai |
| | Hong Kong | | Silicon Valley |
| | Houston | | Singapore |
| | London | | Tel Aviv |
| | Los Angeles | | Tokyo |
| | Madrid | | Washington, D.C. |
Oscar Health, Inc.
75 Varick Street, 5th Floor
New York, New York 10013
| | Re: | Registration Statement on Form S-8; 4,968,684 shares of Class A Common Stock, par value $0.00001 per share, of Oscar Health, Inc. |
To the addressees set forth above:
We have acted as special counsel to Oscar Health, Inc., a Delaware corporation (the “Company”), in connection with the registration by the Company of an aggregate of 4,968,684 shares (the “Shares”) of Class A common stock, par value $0.00001 per share (the “Class A Common Stock”), of the Company issuable under the Company’s 2021 Incentive Award Plan (the “2021 Plan”). The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on August 12, 2022 (the “Registration Statement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the prospectus forming a part thereof, other than as expressly stated herein with respect to the issuance of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon the foregoing and upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein only as to the General Corporation Law of the State of Delaware, as amended (the “DCGL”), and we express no opinion with respect to any other laws.
Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the recipients thereof, and have been issued by the Company for legal consideration in excess of par value in the circumstances contemplated by the 2021 Plan, assuming in each case that the individual grants or awards under the 2021 Plan are duly authorized by all necessary corporate action and duly granted or awarded and exercised in accordance with the requirements of law and the 2021 Plan (and the agreements
